Page 455 - 30917_ASHG_Complete

This is a SEO version of 30917_ASHG_Complete. Click here to view full version

« Previous Page Table of Contents Next Page »
Gignoux, C. R., 23andMe, Inc. - 1 (471T)
Glorieux, F., Novartis - 2 (Session 8)
Goker-Alpan, O., Shire HGT - 2, 5, 8, 11, 14;
Genzyme Inc - 2, 5, 8, 11, 14; Amicus - 14; Pfizer-
Protalix - 5, 11, 14 (1448F)
Gordon, L., Hypogen, Inc - 10, 13; Novartis - 2;
Daiichi Sankyo - 2; Merck - 2 (372W)
Greenberg, C., Enobia Pharma - 2, 5 (1436F)
Gu, J., Life Technologies - 3 (937F)
Gunn, S., CombiMatrix Diagnostics - 3 (999F)
Hajebrahimi, Z., Tarbiat Modares University - 2 (513W)
Han, J., iRepertoire - 3, 10, 14 (818F)
Happe, S., Agilent Technologies - 3; Pacific
Biosciences - 3 (915F)
Harmatz, P., BioMarin Pharmaceutical Inc - 2, 5, 11,
14 (1314T)
Hartung, R., Actelion - 14 (1293F)
Hellemans, J., Biogazelle - 4 (267)
Herzog, A., German Glycogenosis Family Support
Group - 2 (1301T)
Hinds, D. A., 23andMe, Inc. - 1, 3; Johnson &
Johnson, Inc. - 1, 3 (417T)
Holstege, H., Life Technologies - 9, 12 (191)
Hong, E. P., Industry Academic Cooperation
Foundation of Hallym Univ. - 2 (387T)
Hovanes, K., CombiMatrix Diagnostics - 3 (1445T)
Huang, L., GSK - 3 (1432F)
Hung, S.-C., Life Technologies - 3 (1241F)
Jacobs, S., Complete Genomics - 3 (860T)
Kamath, R. S., Genzyme Corporation - 5 (1461F)
Kamberov, E., Rubicon Genomics - 1, 3, 10 (916F)
Keyser, M., DNASTAR, Inc. - 3, 10; NIH - 2 (915W)
Khan, A., Genzyme Corporation - 2, 5, 7, 8, 14; Shire
HGT - 2, 8, 5; Pfizer - 7; Actelion Corporation - 8
(1318T)
Khan, W. A., Cytognomix Inc. - 2, 3 (1258W)
Kido, J., Global COE Program from the Japanese
Society for the Promoti - 2; Ministry of Health,
Labor and Welfare - 2; the Ministry of Education,
Culture, Sports, Science and Tech - 2 (1339F)
Kim, K., BioMarin Pharmaceutical, Inc. - 2, 5 (1449F)
Kim, S., TheragenEtex - 1, 3 (Session 2)
Kloiber, S., Affectis Pharmaceuticals - 11 (561W)
Koch, S., World Anti-Doping Agency - 2 (1404F)
Koehler, R. T., QuantaLife - 1, 3 (916W)
Kroese, M., UK Genetic Testing Network - 3 (1352F)
Lacap, P., Public Health Agency of Canada - 3 (882F)
Lambert, J., Caliper Life Sciences - 3 (861T)
Langmore, J., Rubicon Genomics - 1, 3, 10 (1233F)
Lansdorp, P., Repeat Diagnostics Inc. - 4 (Session 9)
Lavastre, V., CIHR - 2; FRSQ - 2 (602F)
Ledbetter, D., Roche Nimbelgen - 5; GeneDx - 5;
Celula - 5 (Session 44)
Lee, B., Hyperion Therapeutics - 2; Biomarin - 5;
Amgen - 12; Genzyme - 12 (Session 8)
Leon, D., Life Technologies - 3 (818W)
Levin, T. M., Seaside Therapeutics - 2; PharmaNet -
5; Novartis - 5; BioMarin - 5 (534F)
- 2; Programa de Bolsas REUNI/UFCSPA - 2
(1408F)
Lin, E., Agilent Technologies - 3 (934T)
Lindén, M., BiogenIdec - 2, 5; MerckSerono - 2, 5;
Bayer Schering - 2, 5; SanofiAventis - 2, 5 (551T)
Link, D. R., RainDance Technologies - 3 (1232F)
Loomis, E., Pacific Biosciences of California Inc. -
12 (921T)
Lorget, F., BioMarin - 3; INSERM - 5, 12 (1484F)
Lu, Y., Affymetrix Inc. - 1, 3 (444F)
Lupski, J., Athena Diagnostics - 8; Ion Torrent
Systems - 1 (Session 2)
Lusa, A. L. G., UNICAMP - 2 (780W)
Macciardi, F., NIH - 2 (884W)
MacKenzie, J., Shire - 2, 11, 14; Genzyme - 14
(1299F)
Malhotra, A. K., GenoMind - 11 (1409F)
Martinelli Boneschi, F., Prof. Giancarlo Comi - 5; Dr
Vittorio Martinelli - 14 (893T)
Martis, S., MRC Holland - 12 (1410F)
Mascarello, J. T., Esoterix Genetic Laboratories, LL
3 (1281T)
Mason, C. E., Illumina, In.c - 12 (171)
McGinniss, M. J., Caris Life Sciences - 1; Prometh
Laboratories - 1 (1200T)
Meek, I., Caliper Life Sciences - 3 (865T)
Menghrajani, K., Pfizer, Inc. - 2 (343W)
Meredith, G., Life Technologies Corp - 1, 3 (866T)
Mikula, M., Quest Diagnostics - 1, 3 (1058F)
Mooser, V., GlaxoSmithKline - 1, 3 (895T)
Mountain, J. L., 23andMe, Inc. - 1, 3 (466W)
Munne, S., Reprogenetics - 4 (1457W)
Muntau, A. C., Merck Serono SA - 3, 5, 11, 15
(1303T)
Neill, N. J., Signature Genomic Laboratories,
PerkinElmer Inc. - 3 (130)
Nixon, R. A., Takeda Pharmaceuticals - 5, 11; Amg
- 11; Amicus Pharmaceuticals - 12 (Session 63)
Nurmi, E. L., Seaside Therapeutics - 2; PharmaNet
5; Novartis - 5; BioMarin - 5 (1414F)
Nutter, R., Life Technologies - 3 (791F)
Oitmaa, E., Asper Biotech Ltd - 3 (1447W)
O’Roak, B. J., Yale University - 10 (20)
Pabón-Peña, C., Agilent Technologies - 3 (839F)
Packman, W., Shire HGT - 2 (1048F)
Papenhausen, P., LabCorp - 3 (1287W)
Pare, G., sanofi-aventis - 2, 5; Bristol-Myers Squib
2, 5 (1416F)
Patel, C., Life Technologies - 3 (915T)
Pazoki, R., Netherlands Heart Foundation - 2; ICIN
The Netherlands Heart Institute - 3; Leducq
Foundation - 2; Center for Translational Molecula
Medicine (COHFAR) - 2 (326F)
Pellegrino, L., Amicus Therapeutics - 3 (1462F)
Perrin, D., Illumina, Inc. - 12 (936T)
Peters, B. A., Complete Genomics - 1, 3; Eli Lilly -
3 (930W)
Peterschmitt, M. J., Genzyme Corporation - 3 (146